IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Extensive-stage Small Cell Lung Cancer
NantCell, Inc.monoclonal_antibodyPhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 30/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Extensive-stage Small Cell Lung Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Adebelimab Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 | BBB |
Guadecitabine Shadia Jalal, MD | Phase 2 | BB |
gx15-070ms Cephalon | Phase 3 | CCC |
Lucitanib Haihe Biopharma Co., Ltd. | Phase 2/3 | CCC |
IMMUNOGLOBULIN G2, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR) (HUMAN MONOCLONAL 2.12.1 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL 2.12.1 LIGHT CHAIN, DIMER NantCell, Inc. | Phase 1/2 | CC |
bnt411 BioNTech SE | Phase 1/2 | CC |
Neoantigen Dna Vaccine Washington University School of Medicine | Phase 2 | CC |
Toripalimab Chinese Academy of Medical Sciences | Phase 1 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →